2025
SJR Q3
JCR Q4 · 1,9
14 matched articles
SCIE
Journal detail
Growth Factors
- Publisher
- Taylor and Francis Ltd.
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0897719410292292
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,617
- Quartile Q3
- H-Index 68
- Cites/doc 1,64
- Docs (3y) 63
- Cites (3y) 161
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1,9
- 5Y JIF 2,5
- JCI 0,33
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cell Biology Q3
- Clinical Biochemistry Q3
- Endocrinology Q3
Areas
- Biochemistry, Genetics and Molecular Biology
WoS categories
- Cell Biology | Endocrinology & Metabolism
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,617 | 1,9 | 2,5 | 0,33 | Q4 | 68 |
| 2024 | Q3 | Q4 | 0,459 | 1,7 | 2 | 0,32 | Q4 | 66 |
| 2023 | Q3 | Q4 | 0,495 | 1,8 | 2,9 | 0,32 | Q4 | 66 |
| 2022 | Q3 | Q4 | 0,438 | 1,8 | 2,4 | 0,25 | Q4 | 66 |
| 2021 | Q3 | Q4 | 0,525 | 2,4 | 2,8 | 0,3 | Q4 | 66 |
| 2020 | Q2 | Q4 | 0,69 | 2,5 | 2,3 | 0,3 | Q4 | 66 |
| 2019 | Q3 | Q4 | 0,544 | 1,5 | 1,8 | 0,31 | Q4 | 66 |
| 2018 | — | Q4 | — | 1,2 | 2 | 0,35 | Q4 | — |
| 2017 | Q2 | Q4 | 0,707 | 1,8 | 2,3 | 0,39 | Q3 | 66 |
| 2016 | Q2 | Q4 | 0,721 | 1,6 | 2,7 | — | — | 66 |
| 2015 | Q1 | Q3 | 1,203 | 2 | 2,6 | — | — | 66 |
| 2014 | Q1 | Q2 | 1,918 | 3,4 | 3 | — | — | 66 |
| 2013 | Q1 | Q2 | 1,353 | 3,1 | 2,6 | — | — | 66 |
| 2012 | Q2 | Q3 | 0,795 | 2,2 | 2,3 | — | — | 66 |
| 2011 | Q2 | Q4 | 0,804 | 1,6 | 2,4 | — | — | 66 |
| 2010 | Q1 | Q2 | 1,141 | 2,8 | 3,1 | — | — | 66 |
| 2009 | — | Q3 | — | 2,5 | 3,9 | — | — | — |
| 2008 | — | Q3 | — | 2,5 | 3,3 | — | — | — |
| 2007 | — | Q2 | — | 3,7 | 3,9 | — | — | — |
| 2006 | — | Q1 | — | 3,9 | — | — | — | — |
| 2005 | — | Q3 | — | 1,8 | — | — | — | — |
| 2004 | — | Q3 | — | 1,9 | — | — | — | — |
| 2003 | — | Q3 | — | 1,7 | — | — | — | — |
| 2002 | — | Q3 | — | 1,6 | — | — | — | — |
| 2001 | — | Q2 | — | 2,1 | — | — | — | — |
| 2000 | — | Q2 | — | 2,1 | — | — | — | — |
| 1999 | — | Q2 | — | 2,1 | — | — | — | — |
| 1998 | — | Q2 | — | 2,3 | — | — | — | — |
| 1997 | — | Q2 | — | 2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CELL BIOLOGY | SCIE | Q4 | Q4 | 179/207 |
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q4 | 154/198 |
| 2024 | CELL BIOLOGY | SCIE | Q4 | Q4 | 181/204 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q4 | 153/193 |
| 2023 | CELL BIOLOGY | SCIE | Q4 | Q4 | 179/205 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q4 | 144/186 |
| 2022 | CELL BIOLOGY | SCIE | Q4 | Q4 | 175/191 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q4 | 132/145 |
| 2021 | CELL BIOLOGY | SCIE | Q4 | Q4 | 166/195 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q4 | 123/146 |
| 2020 | CELL BIOLOGY | SCIE | Q4 | Q4 | 152/195 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q4 | 118/146 |
| 2019 | CELL BIOLOGY | SCIE | Q4 | Q4 | 175/195 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q4 | 128/143 |
| 2018 | CELL BIOLOGY | SCIE | Q4 | Q4 | 184/193 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q4 | 132/145 |
| 2017 | CELL BIOLOGY | SCIE | Q4 | Q4 | 157/190 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q3 | 115/142 |
| 2016 | CELL BIOLOGY | SCIE | Q4 | — | 159/190 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 112/138 |
| 2015 | CELL BIOLOGY | SCIE | Q4 | — | 141/187 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 97/133 |
| 2014 | CELL BIOLOGY | SCIE | Q2 | — | 89/184 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 50/128 |
| 2013 | CELL BIOLOGY | SCIE | Q3 | — | 101/185 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 54/124 |
| 2012 | CELL BIOLOGY | SCIE | Q3 | — | 134/185 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 76/122 |
| 2011 | CELL BIOLOGY | SCIE | Q4 | — | 146/181 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 92/122 |
| 2010 | CELL BIOLOGY | SCIE | Q3 | — | 106/178 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 58/116 |
| 2009 | CELL BIOLOGY | SCIE | Q3 | — | 101/162 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 60/105 |
| 2008 | CELL BIOLOGY | SCIE | Q3 | — | 91/157 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 57/93 |
| 2007 | CELL BIOLOGY | SCIE | Q2 | — | 57/156 |
| 2007 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 27/92 |
| 2006 | CELL BIOLOGY | SCIE | Q2 | — | 49/156 |
| 2006 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 22/93 |
| 2005 | CELL BIOLOGY | SCIE | Q3 | — | 108/153 |
| 2005 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 56/89 |
| 2004 | CELL BIOLOGY | SCIE | Q3 | — | 99/155 |
| 2004 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 50/87 |
| 2003 | CELL BIOLOGY | SCIE | Q3 | — | 103/156 |
| 2003 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 58/88 |
| 2002 | CELL BIOLOGY | SCIE | Q3 | — | 96/153 |
| 2002 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 49/88 |
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 136/308 |
| 2001 | CELL BIOLOGY | SCIE | Q3 | — | 77/147 |
| 2000 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 138/310 |
| 2000 | CELL BIOLOGY | SCIE | Q3 | — | 74/147 |
| 1999 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 130/295 |
| 1999 | CELL BIOLOGY | SCIE | Q2 | — | 66/141 |
| 1998 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 103/295 |
| 1998 | CELL BIOLOGY | SCIE | Q2 | — | 53/139 |
| 1997 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 107/253 |
| 1997 | CELL BIOLOGY | SCIE | Q2 | — | 54/130 |